Table 5.
Characteristic | ACQ Full | ACQ Symptoms and FEV1% | ACQ Symptoms and β2-Agonist Use | ACQ Symptoms | |||||||
OR (95% CI) | P Value | OR (95% CI) | P Value | OR (95% CI) | P Value | OR (95% CI) | P Value | ||||
High OSA risk | 2.87 (1.54-5.32) | .0009 | 2.45 (1.37-4.41) | .003 | 3.46 (1.88-6.39) | < .0001 | 3.06 (1.67-5.60) | .0003 | |||
Obesity | 1.43 (0.80-2.54) | .23 | 1.80 (1.06-3.08) | .03 | 1.17 (0.66-2.07) | .60 | 1.43 (0.81-2.51) | .21 | |||
GERD | 3.00 (1.70-5.31) | .0002 | 2.84 (1.68-4.82) | .0001 | 2.68 (1.55-4.64) | .0004 | 3.10 (1.79-5.37) | < .0001 | |||
Nasal diseases | |||||||||||
Rhinitis | 0.38 (0.14-1.02) | .055 | 0.26 (0.10-0.70) | .008 | 0.20 (0.07-0.54) | .001 | 0.21 (0.08-0.57) | .002 | |||
Sinusitis | 0.55 (0.29-1.06) | .08 | 0.74 (0.41-1.34) | .32 | 0.91 (0.50-1.67) | .76 | 0.97 (0.53-1.76) | .92 | |||
Nasal polyps | 2.37 (1.08-5.24) | .03 | 1.78 (0.84-3.76) | .13 | 1.41 (0.65-3.05) | .38 | 1.35 (0.62-2.93) | .45 | |||
Psychiatric disease | 1.79 (0.97-3.27) | .06 | 2.12 (1.23-3.77) | .007 | 2.06 (1.16-3.67) | .01 | 2.06 (1.16-3.65) | .01 |